Gaps and barriers between numbers of persons with HIV preexposure prophylaxis (PrEP) indications and those prescribed PrEP are substantial in the US, especially among persons in female, black, and Hispanic populations. This according to a new CDC report that analyzed 2014‒2016 data to estimate the number of persons prescribed PrEP (users) in the US and to describe their demographic characteristics, including race/ethnicity. Researchers found:
- In 2016, among 78,360 persons who filled prescriptions for PrEP in the US, women accounted for only 4.7%.
- Among PrEP users with available data, 68.7%, 11.2%, 13.1%, and 4.5% were white, black, Hispanic, and Asian, respectively.
- ~7% of the estimated 1.1 million persons who had indications for PrEP were prescribed PrEP in 2016.
- Focused efforts are needed to increase the impact of PrEP in the US.
Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1147–1150. doi:10.15585/mmwr.mm6741a3.
This Week's Must Reads
Must Reads in Infectious Diseases
Rapid Point of Care Test for Influenza, J Am Board Fam Med; 2019 Mar; Dale, et al
Invasive GBS Infections in Nonpregnant US Adults, JAMA Intern Med; ePub 2019 Feb 18; Francois Watkins, et al
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al
Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al
Hospitalization Trends for Drug-Use Associated IE, Ann Intern Med; ePub 2018 Dec 4; Schranz, et al